Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.

BMC Cancer · 2022 · PMC9118720 · PMID 35585577

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

showed, in the final report of the KPNC data, that an increasing trend of breast cancer could be observed with increasing dose and duration of pioglitazone in sensitivity analyses [ 6 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.